CAS Number 1379686-29-9 ChemSpider 28487552 Formula C23H31ClN4O3S Molar mass 479.0352 g/mol | PubChem CID 57394021 ChEMBL CHEMBL1961797 3D model (Jmol) Interactive image | |
![]() | ||
SR9011 is a research drug that was developed by Professor Thomas Burris of Scripps as an agonist of Rev-ErbAα with a half-maximum inhibitory concentration (IC50) = 790 nM for Rev-Erbα and IC50 = 560 nM for Rev-ErbAβ.
References
SR9011 Wikipedia(Text) CC BY-SA